Kato Y, Udagawa H, Matsumoto S, Izumi H, et al. Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-Asia. Lung Cancer 2024;197:107992.
PMID: 39423763